Statins have emerged as a revolutionary class of drugs that have significantly enhanced heart health outcomes, saving millions of lives by effectively lowering cholesterol levels and mitigating the risk of heart attacks and strokes. However, for many individuals, the advantages of statins are accompanied by a troubling downside: muscle pain and weakness. In rare instances, severe muscle breakdown can occur, leading to potentially life-threatening conditions such as kidney failure. Recent research conducted by scientists at the University of British Columbia (UBC) and the University of Wisconsin-Madison has shed light on the molecular mechanisms underlying these side effects, opening doors for the development of a new generation of statins that could minimize these adverse reactions.

Understanding Statins and Muscle Interactions

Research teams have utilized high-resolution macromolecular cryo-electron microscopy, a powerful imaging technique, to investigate how statins interact with a crucial muscle protein known as the ryanodine receptor (RyR1). This protein is integral for regulating calcium release in muscle cells, allowing for proper muscle contraction. The findings reveal that statins can bind to the RyR1 protein in a manner that continuously opens this calcium channel, leading to calcium leakage. This toxic effect can result in muscle damage, explaining why some patients experience discomfort or severe complications.

"We were able to see, almost atom by atom, how statins latch onto this channel." – Dr. Steven Molinarolo, lead author

Mechanism of Statin-Induced Muscle Damage

The study specifically analyzed atorvastatin, one of the most widely prescribed members of the statin class. The research indicates that statins bind to the RyR1 protein in an unconventional manner, with three molecules clustering inside a specific pocket of the protein. The binding process occurs as follows:

  1. The first statin molecule attaches to the closed channel, priming it for activation.
  2. Subsequently, two additional molecules wedge into the same pocket, forcing the channel to open.

This remarkable visualization provides clarity on how statins activate the ryanodine receptor channel, laying a foundational roadmap for future statin development aimed at minimizing interactions that lead to muscle damage.

Future Directions for Statin Development

Researchers have highlighted the potential implications of these findings on the design of future statins. By targeting specific regions of the statin molecule responsible for the negative side effects, it may be possible to retain the cholesterol-lowering capabilities while diminishing the associated muscle problems. This could drastically improve patient adherence to prescribed statin therapy.

Implications for Patient Care

While severe muscle damage is rare, milder symptoms such as muscle aches and fatigue are common among the more than 200 million statin users worldwide. These symptoms frequently lead to discontinuation of the medication. The insights gained from this research could provide solutions to improve treatment adherence, allowing patients to reap the life-saving benefits of statins without the fear of debilitating side effects.

Technological Advancements in Drug Safety

This study illustrates the significance of advanced imaging technologies in advancing our understanding of drug interactions and enhancing medical breakthroughs. The UBC Faculty of Medicine's high-resolution macromolecular cryo-electron microscopy facility has played a crucial role, offering clarity on the statin-protein interactions that affect patient safety. Such technological advancements hold the promise of shaping future therapies that are not only effective but also safer for patients.

"Our goal is to make statins even safer, so patients can benefit without fear of serious side effects." – Dr. Filip Van Petegem, senior author

Conclusions

The research findings from UBC and the University of Wisconsin-Madison offer significant insights into the mechanisms by which statins can induce muscle damage. With the potential to develop modified versions of statins that effectively lower cholesterol while minimizing harmful side effects, the future of cardiovascular therapy looks promising. For millions of individuals relying on statins, this could mean experiencing improved muscle function and overall quality of life while continuing to engage in vital treatments.

References

  • Molinarolo, S., et al. (2025). Cryo-electron microscopy reveals sequential binding and activation of Ryanodine Receptors by statin triplets. Nature Communications.
  • University of British Columbia Research Study.
  • University of Wisconsin-Madison Collaboration.

For additional reading, visit: How statins harm muscles—and how to stop it